Ramasubramanian Ocular Oncology

1. Auflage 2019
ISBN: 978-981-13-7538-5
Verlag: Springer Singapore
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 114 Seiten, eBook

Reihe: Current Practices in Ophthalmology

This book concentrates on ocular oncology covering the latest advances in both adult and pediatric oncology. The topics covered are: retinoblastoma, melanoma, graft vs. host disease, squamous cell neoplasia, intraocular lymphoma, coats disease, and choroidal hemangioma. Each chapter is written by an expert in the field and covers the most recent developments in management. As part of the series “Current Practices in ophthalmology” this volume is meant for residents, fellows-in-training, generalist ophthalmologists and specialists alike.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Ramasubramanian, Aparna

Inhaltsverzeichnis

Chapter 1: Current Management of Retinoblastoma.- Chapter 2: Diagnosis and Management of Small Choroidal Melanoma.- Chapter 3: Genetic Implications of Ocular Melanoma.- Chapter 4: Advancements in the Management of Optic Pathway Gliomas.- Chapter 5: Current Management of Ocular Squamous Cell Neoplasia.- Chapter 6: Intraocular Lymphoma.- Chapter 7: Update on Management of Coats Disease.- Chapter 8: Management of Choroidal Hemangioma.

Über Autor(innen)

Aparna Ramasubramanian is an assistant professor of pediatric ophthalmology and oncology at University of Louisville. She did her medical school at University of Kerala, India followed by ophthalmology residency in Indiana University. She received fellowship training in ocular oncology at Wills Eye Institute and in pediatric ophthalmology at Children’s Hospital, Boston. Her primary research and clinical interest is retinoblastoma and she is the author of the leading textbook on Retinoblastoma. She has published extensively in peer-reviewed journals and is a reviewer for all leading ophthalmology journals. Besides retinoblastoma, she also treats the whole range of pediatric and adult eye tumors and keeps a keen interest in secondary eye manifestations of cancer.